Ontology type: schema:MonetaryGrant
2013-2018
FUNDING AMOUNT26360120 USD
ABSTRACTApplying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1) translation, crucial to having health impact, translation into effective clinical practice (T2), care delivery and public health (TS), and health policy ('T4). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (Tl) translation and crucially for having health impact, translation into effective clinical practice (T2), care delivery and public health (TS-), and health policy (?T4). More... »
URLhttp://projectreporter.nih.gov/project_info_description.cfm?aid=9278321
http://scigraph.springernature.com/grant.2705244
DIMENSIONShttps://app.dimensions.ai/details/grant/grant.2705244
NIHUL1TR001064
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"type": "DefinedTerm"
}
],
"amount": {
"currency": "USD",
"type": "MonetaryAmount",
"value": "26360120"
},
"description": "Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1) translation, crucial to having health impact, translation into effective clinical practice (T2), care delivery and public health (TS), and health policy ('T4). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (Tl) translation and crucially for having health impact, translation into effective clinical practice (T2), care delivery and public health (TS-), and health policy (?T4).",
"endDate": "2018-09-30T00:00:00Z",
"funder": {
"id": "https://www.grid.ac/institutes/grid.429651.d",
"type": "Organization"
},
"id": "sg:grant.2705244",
"identifier": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"2705244"
]
},
{
"name": "nih_id",
"type": "PropertyValue",
"value": [
"UL1TR001064"
]
}
],
"inLanguage": [
"en"
],
"keywords": [
"CTR home",
"T1-T4 spectrum",
"Tufts CTSl",
"Tufts hospitals",
"translational gap",
"collaborative CTR",
"novel methods;4",
"Brandeis University",
"translation",
"effective clinical practice",
"Section I",
"health impacts",
"biomedical sciences",
"RAND Corporation",
"bedside",
"widespread impact",
"Aim 2",
"T2",
"Tufts Clinical",
"translational research",
"institutionsjS",
"Instmctions",
"opportunity",
"TS-",
"strategically-",
"entire spectrum",
"way",
"health",
"Section III",
"aim",
"Tl",
"high-quality resources",
"Northeastern University",
"development",
"relevance",
"Translational Science Institute",
"services",
"tai^eted education",
"second CTSA",
"care delivery",
"public health",
"specific focus",
"Tufts CTSl building",
"partners",
"public need",
"spectmm",
"operationalize",
"pnsmise",
"Section II",
"full-spectrum translational research",
"Aim 1",
"special assets",
"bench",
"platform",
"financial management system",
"full spectrum",
"synergistic resources",
"community",
"committee",
"industry partners",
"health policy",
"other necessary structures",
"training",
"organization",
"field",
"Aim 4",
"central office personnel",
"CTR",
"innovative resources",
"Aim 3",
"Translational Research Institute",
"prior CTR resources",
"national leadership",
"TS",
"T1",
"CTR workforce",
"efficient access",
"education",
"T4",
"infra- stnjcture",
"educational programs",
"partners Include 12 Tufts University schools/research centers",
"promise",
"academic institutions",
"program",
"home",
"commitment",
"Section IV",
"application's four sections",
"CTSL",
"disciplines",
"clinical ahd",
"policy",
"sen/ices"
],
"name": "Tufts Clinical and Translational Research Institute",
"recipient": [
{
"id": "https://www.grid.ac/institutes/grid.429997.8",
"type": "Organization"
},
{
"affiliation": {
"id": "https://www.grid.ac/institutes/grid.429997.8",
"name": "TUFTS UNIVERSITY BOSTON",
"type": "Organization"
},
"familyName": "SELKER",
"givenName": "HARRY P.",
"id": "sg:person.01360626137.26",
"type": "Person"
},
{
"member": "sg:person.01360626137.26",
"roleName": "PI",
"type": "Role"
}
],
"sameAs": [
"https://app.dimensions.ai/details/grant/grant.2705244"
],
"sdDataset": "grants",
"sdDatePublished": "2021-01-20T02:59",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_21.xml.gz",
"startDate": "2013-09-26T00:00:00Z",
"type": "MonetaryGrant",
"url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9278321"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2705244'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2705244'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2705244'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2705244'
This table displays all metadata directly associated to this object as RDF triples.
138 TRIPLES
19 PREDICATES
116 URIs
108 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:grant.2705244 | schema:about | anzsrc-for:2211 |
2 | ″ | schema:amount | Na98a157a228640888155fc2e30c27388 |
3 | ″ | schema:description | Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1) translation, crucial to having health impact, translation into effective clinical practice (T2), care delivery and public health (TS), and health policy ('T4). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (Tl) translation and crucially for having health impact, translation into effective clinical practice (T2), care delivery and public health (TS-), and health policy (?T4). |
4 | ″ | schema:endDate | 2018-09-30T00:00:00Z |
5 | ″ | schema:funder | https://www.grid.ac/institutes/grid.429651.d |
6 | ″ | schema:identifier | N0f574647d91b48548b9f1bb6bf965039 |
7 | ″ | ″ | N9f1a9298362c4931a5d03d14cf989227 |
8 | ″ | schema:inLanguage | en |
9 | ″ | schema:keywords | Aim 1 |
10 | ″ | ″ | Aim 2 |
11 | ″ | ″ | Aim 3 |
12 | ″ | ″ | Aim 4 |
13 | ″ | ″ | Brandeis University |
14 | ″ | ″ | CTR |
15 | ″ | ″ | CTR home |
16 | ″ | ″ | CTR workforce |
17 | ″ | ″ | CTSL |
18 | ″ | ″ | Instmctions |
19 | ″ | ″ | Northeastern University |
20 | ″ | ″ | RAND Corporation |
21 | ″ | ″ | Section I |
22 | ″ | ″ | Section II |
23 | ″ | ″ | Section III |
24 | ″ | ″ | Section IV |
25 | ″ | ″ | T1 |
26 | ″ | ″ | T1-T4 spectrum |
27 | ″ | ″ | T2 |
28 | ″ | ″ | T4 |
29 | ″ | ″ | TS |
30 | ″ | ″ | TS- |
31 | ″ | ″ | Tl |
32 | ″ | ″ | Translational Research Institute |
33 | ″ | ″ | Translational Science Institute |
34 | ″ | ″ | Tufts CTSl |
35 | ″ | ″ | Tufts CTSl building |
36 | ″ | ″ | Tufts Clinical |
37 | ″ | ″ | Tufts hospitals |
38 | ″ | ″ | academic institutions |
39 | ″ | ″ | aim |
40 | ″ | ″ | application's four sections |
41 | ″ | ″ | bedside |
42 | ″ | ″ | bench |
43 | ″ | ″ | biomedical sciences |
44 | ″ | ″ | care delivery |
45 | ″ | ″ | central office personnel |
46 | ″ | ″ | clinical ahd |
47 | ″ | ″ | collaborative CTR |
48 | ″ | ″ | commitment |
49 | ″ | ″ | committee |
50 | ″ | ″ | community |
51 | ″ | ″ | development |
52 | ″ | ″ | disciplines |
53 | ″ | ″ | education |
54 | ″ | ″ | educational programs |
55 | ″ | ″ | effective clinical practice |
56 | ″ | ″ | efficient access |
57 | ″ | ″ | entire spectrum |
58 | ″ | ″ | field |
59 | ″ | ″ | financial management system |
60 | ″ | ″ | full spectrum |
61 | ″ | ″ | full-spectrum translational research |
62 | ″ | ″ | health |
63 | ″ | ″ | health impacts |
64 | ″ | ″ | health policy |
65 | ″ | ″ | high-quality resources |
66 | ″ | ″ | home |
67 | ″ | ″ | industry partners |
68 | ″ | ″ | infra- stnjcture |
69 | ″ | ″ | innovative resources |
70 | ″ | ″ | institutionsjS |
71 | ″ | ″ | national leadership |
72 | ″ | ″ | novel methods;4 |
73 | ″ | ″ | operationalize |
74 | ″ | ″ | opportunity |
75 | ″ | ″ | organization |
76 | ″ | ″ | other necessary structures |
77 | ″ | ″ | partners |
78 | ″ | ″ | partners Include 12 Tufts University schools/research centers |
79 | ″ | ″ | platform |
80 | ″ | ″ | pnsmise |
81 | ″ | ″ | policy |
82 | ″ | ″ | prior CTR resources |
83 | ″ | ″ | program |
84 | ″ | ″ | promise |
85 | ″ | ″ | public health |
86 | ″ | ″ | public need |
87 | ″ | ″ | relevance |
88 | ″ | ″ | second CTSA |
89 | ″ | ″ | sen/ices |
90 | ″ | ″ | services |
91 | ″ | ″ | special assets |
92 | ″ | ″ | specific focus |
93 | ″ | ″ | spectmm |
94 | ″ | ″ | strategically- |
95 | ″ | ″ | synergistic resources |
96 | ″ | ″ | tai^eted education |
97 | ″ | ″ | training |
98 | ″ | ″ | translation |
99 | ″ | ″ | translational gap |
100 | ″ | ″ | translational research |
101 | ″ | ″ | way |
102 | ″ | ″ | widespread impact |
103 | ″ | schema:name | Tufts Clinical and Translational Research Institute |
104 | ″ | schema:recipient | N7ec3406f36204e9aa56f608b2b06d699 |
105 | ″ | ″ | sg:person.01360626137.26 |
106 | ″ | ″ | https://www.grid.ac/institutes/grid.429997.8 |
107 | ″ | schema:sameAs | https://app.dimensions.ai/details/grant/grant.2705244 |
108 | ″ | schema:sdDatePublished | 2021-01-20T02:59 |
109 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
110 | ″ | schema:sdPublisher | N6cfcd179b1c945e1a9a89149b172eb68 |
111 | ″ | schema:startDate | 2013-09-26T00:00:00Z |
112 | ″ | schema:url | http://projectreporter.nih.gov/project_info_description.cfm?aid=9278321 |
113 | ″ | sgo:license | sg:explorer/license/ |
114 | ″ | sgo:sdDataset | grants |
115 | ″ | rdf:type | schema:MonetaryGrant |
116 | N0f574647d91b48548b9f1bb6bf965039 | schema:name | nih_id |
117 | ″ | schema:value | UL1TR001064 |
118 | ″ | rdf:type | schema:PropertyValue |
119 | N6cfcd179b1c945e1a9a89149b172eb68 | schema:name | Springer Nature - SN SciGraph project |
120 | ″ | rdf:type | schema:Organization |
121 | N7ec3406f36204e9aa56f608b2b06d699 | schema:member | sg:person.01360626137.26 |
122 | ″ | schema:roleName | PI |
123 | ″ | rdf:type | schema:Role |
124 | N9f1a9298362c4931a5d03d14cf989227 | schema:name | dimensions_id |
125 | ″ | schema:value | 2705244 |
126 | ″ | rdf:type | schema:PropertyValue |
127 | Na98a157a228640888155fc2e30c27388 | schema:currency | USD |
128 | ″ | schema:value | 26360120 |
129 | ″ | rdf:type | schema:MonetaryAmount |
130 | anzsrc-for:2211 | schema:inDefinedTermSet | anzsrc-for: |
131 | ″ | rdf:type | schema:DefinedTerm |
132 | sg:person.01360626137.26 | schema:affiliation | https://www.grid.ac/institutes/grid.429997.8 |
133 | ″ | schema:familyName | SELKER |
134 | ″ | schema:givenName | HARRY P. |
135 | ″ | rdf:type | schema:Person |
136 | https://www.grid.ac/institutes/grid.429651.d | ″ | schema:Organization |
137 | https://www.grid.ac/institutes/grid.429997.8 | schema:name | TUFTS UNIVERSITY BOSTON |
138 | ″ | rdf:type | schema:Organization |